Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation …

FN Varra, M Varras, VK Varra… - Molecular …, 2024 - spandidos-publications.com
Obesity reaches up to epidemic proportions globally and increases the risk for a wide
spectrum of co-morbidities, including type-2 diabetes mellitus (T2DM), hypertension …

Therapeutic potentials of ononin with mechanistic insights: A comprehensive review

MS Bhuia, MA Aktar, R Chowdhury, J Ferdous… - Food Bioscience, 2023 - Elsevier
Ononin is a naturally occurring isoflavone glycoside generally found in various plants like
soybeans, legumes, Chinese licorice, Mongolian milkvetch, kudzu, broccoli, and lupine. The …

Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages

M Groeger, K Matsuo, E Heidary Arash… - Nature …, 2023 - nature.com
Hepatic insulin resistance is recognized as a driver of type 2 diabetes and fatty liver disease
but specific therapies are lacking. Here we explore the potential of human induced …

Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in …

WAA Fadaly, A Elshewy, MTM Nemr, K Abdou… - Bioorganic …, 2024 - Elsevier
A novel series of thiazole derivatives with pyrazole scaffold 16a-l as hybrid rosiglitazone/
celecoxib analogs was designed, synthesized and tested for its PPAR-γ activation, α …

Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose diet

NF Hassan, AH Hassan, MR El-Ansary - Scientific Reports, 2022 - nature.com
The aim of the present study was to investigate the effect of etanercept (ETA)—an anti-tumor
necrosis factor α (TNF-α) monoclonal antibody—on metabolic disorders such as obesity …

Molecular mechanisms involved in fetal programming and disease origin in adulthood

JA Aguayo-Guerrero, S León-Cabrera… - Journal of Pediatric …, 2023 - degruyter.com
Fetal programming occurs during the gestational age when exposure to environmental
stimuli can cause long-term changes in the fetus, predisposing it to develop chronic non …

Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes

J Guan, H Abudouaini, K Lin, K Yang - Diabetology & Metabolic Syndrome, 2024 - Springer
Type 2 diabetes mellitus (T2DM), a prevalent chronic metabolic disorder, is closely linked to
persistent low-grade inflammation, significantly contributing to its development and …

Interleukin‐39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index

SW Nussrat, AH Ad'hiah - Endocrinology, diabetes & …, 2023 - Wiley Online Library
Introduction It is suggested that cytokines play a key role in the pathogenesis of type 2
diabetes mellitus (T2DM). Therefore, this study explored two recently discovered cytokines …

[HTML][HTML] Deciphering the intricacies of immune system dysfunction and its impact on diabetes mellitus: revisiting the communication strategies to manage diabetes …

S Nishad, D Dongare, ACP Tripathi, T Tripathi… - Health Sciences …, 2024 - Elsevier
Type 2 diabetes mellitus (T2DM) is a prevalent chronic condition, accounting for over 90% of
diabetes cases globally, characterized by insulin resistance and chronic hyperglycemia …

Diabetes-modifying Antirheumatic drugs: the roles of Dmards as glucose-lowering agents

M Infante, N Padilla, R Alejandro, M Caprio… - Medicina, 2022 - mdpi.com
Systemic inflammation represents a shared pathophysiological mechanism which underlies
the frequent clinical associations among chronic inflammatory rheumatic diseases (CIRDs) …